Prosecution Insights
Last updated: October 02, 2026
Application No. 17/981,692

VARIETY CORN LINE HID4134

Non-Final OA §112
Filed
Nov 07, 2022
Examiner
KINGDON, CATHY
Art Unit
1663
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Syngenta AG
OA Round
5 (Non-Final)
80%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
976 granted / 1216 resolved
+20.3% vs TC avg
Minimal +2% lift
Without
With
+2.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
27 currently pending
Career history
1239
Total Applications
across all art units

Statute-Specific Performance

§101
5.9%
-34.1% vs TC avg
§103
20.2%
-19.8% vs TC avg
§102
20.3%
-19.7% vs TC avg
§112
39.0%
-1.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1216 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on Aug. 24, 2026, has been entered. Claims 1-20 are pending and are examined in this Office Action. Claim Objections Claim 19 is objected to because of the following informalities: there is an extra space in the second line between “method” and “,”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 19 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Applicant’s arguments in the response received on Aug. 24, 2026, have been fully considered but were not found to be persuasive. Claim 19 reads as follows: “A method of producing a commodity plant product, said method , wherein the product comprises growing a plant from the seed of claim 10, and producing said commodity plant product, wherein said product comprises protein concentrate, protein isolate, starch, meal, flour or oil from said plant.” This claim language is identical to the claim language submitted in the after final response received on Aug. 4, 2026. As explained in the advisory action, this renders the claim indefinite because there are no active method steps. After the recitation of “said method” in line 2, there are no method steps at all. It is completely unclear what a practitioner would need to do to perform the claimed method. This is why the amendment was not entered after final. Applicant asserts that they have amended the claim as suggested (Resp 1). This is incorrect. The Examiner suggested the following claim language as a way to overcome the indefiniteness rejection: - - A method of producing a commodity plant product, said method comprising growing a plant from the seed of claim 10 and producing said commodity plant product, wherein the product comprises protein concentrate, protein isolate, starch, meal, flour or oil from said plant. - - (Advisory Action, Continuation Sheet). Summary Claims 1-18 and 20 are allowed. Claim 19 is rejected. Examiner’s Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to CATHY KINGDON whose telephone number is (571)272-8784. The examiner can normally be reached M-F 9:00 - 5:30 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amjad A Abraham can be reached at (571) 270-7058. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CATHY KINGDON Primary Examiner Art Unit 1663 /CATHY KINGDON/Primary Examiner, Art Unit 1663
Read full office action

Prosecution Timeline

Show 8 earlier events
Oct 31, 2025
Non-Final Rejection mailed — §112
Feb 02, 2026
Response Filed
Feb 02, 2026
Response after Non-Final Action
Jun 05, 2026
Final Rejection mailed — §112
Aug 04, 2026
Response after Non-Final Action
Aug 24, 2026
Request for Continued Examination
Aug 25, 2026
Response after Non-Final Action
Sep 15, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733614
ALFALFA VARIETY C0415SN223
4y 8m to grant Granted Sep 15, 2026
Patent 12733615
ALFALFA VARIETY R0419A3143
2y 6m to grant Granted Sep 15, 2026
Patent 12708084
PEANUT VARIETY 'GEORGIA-SP/RKN'
3y 5m to grant Granted Aug 18, 2026
Patent 12709755
METHODS AND COMPOSITIONS FOR ENHANCED PROTEIN PRODUCTION IN BACILLUS CELLS
2y 6m to grant Granted Aug 18, 2026
Patent 12702099
Canola Hybrid Variety 9CN0099
4y 5m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
80%
Grant Probability
83%
With Interview (+2.5%)
2y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1216 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month